| 2002 |
STK32A (also called YANK1) was identified as a member of the AGC kinase superfamily in the comprehensive catalogue of the human kinome, classifying it as a serine/threonine protein kinase. |
Genomic sequence analysis, cDNA/EST database mining, and phylogenetic classification |
Science |
Medium |
12471243
|
| 2015 |
STK32A protein is N-myristoylated at its N-terminus, as demonstrated by metabolic labeling experiments in both an insect cell-free protein synthesis system and in transfected human cells using radiolabeled myristic acid. |
Cell-free protein synthesis metabolic labeling with [3H]-myristic acid; metabolic labeling in transfected human cells; N-terminal peptide fusion reporter assays |
PloS one |
High |
26308446
|
| 2014 |
STK32A was identified as a candidate N-myristoylated protein using a cell-free bioorthogonal myristic acid analogue labeling approach, supporting its N-myristoylation. |
Cell-free protein synthesis with azide-analogue of myristic acid followed by Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) biotin tagging and Western blot detection |
Analytical biochemistry |
Medium |
25043870
|
| 2017 |
STK32A was identified as part of the human protein-protein interaction network (BioPlex 2.0) via affinity purification-mass spectrometry, placing it within cellular protein communities. |
Affinity purification-mass spectrometry (AP-MS) at proteome scale |
Nature |
Low |
28514442
|
| 2020 |
STK32A was identified as part of the human binary protein interactome (HuRI), providing candidate interaction partners via yeast two-hybrid screening. |
Systematic yeast two-hybrid (Y2H) binary interaction screening across the human ORFeome |
Nature |
Low |
32296183
|
| 2020 |
STK32A was identified as part of a kinase interaction network by AP-MS, expanding the known functional associations for this understudied kinase. |
Mass-spectrometry-based affinity purification covering >300 human kinases |
Molecular cell |
Low |
32707033
|
| 2020 |
STK32A promotes NSCLC cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) by activating NF-κB p65 phosphorylation. The transcription factor RUNX2 binds to and upregulates STK32A expression, and miR-130a-5p suppresses this pathway by directly targeting RUNX2, thereby indirectly reducing STK32A levels and inhibiting tumor growth in vivo. |
Dual-luciferase reporter assay (miR-130a-5p→RUNX2 interaction); RT-qPCR and Western blot (STK32A and NF-κB p65 phosphorylation); cell viability (CCK-8), colony formation, Transwell migration/invasion assays; in vivo xenograft tumor model with RUNX2 overexpression |
BMC cancer |
Medium |
32571328
|
| 2023 |
STK32A functions as a downstream effector negatively regulated by the transcription factor EMX2 in mouse inner ear hair cells. STK32A is expressed in EMX2-negative hair cells on one side of the line of polarity reversal (LPR). STK32A is necessary to align the intrinsic stereociliary bundle polarity with core planar cell polarity (PCP) proteins in EMX2-negative regions and is sufficient to reorient bundles when ectopically expressed in EMX2-positive regions. STK32A regulates planar polarity by controlling the apical localization of the transmembrane receptor GPR156. |
Mouse genetic loss-of-function (Stk32a knockout), ectopic gain-of-function expression, immunofluorescence localization of GPR156 and PCP proteins, confocal imaging of stereociliary bundle orientation in vestibular maculae |
eLife |
High |
37144879
|
| 2025 |
Genetic epistasis experiments in mice with combined Gpr156/Stk32a or Emx2/Stk32a mutations established that: (1) GPR156 reverses stereociliary bundle orientation relative to the PCP axis but is blocked by STK32A activity; (2) EMX2 establishes the LPR boundary by repressing Stk32a transcription; and (3) these functional relationships are conserved in the cochlea despite the absence of polarity reversal there. |
Double-mutant mouse genetic epistasis (Gpr156;Stk32a and Emx2;Stk32a compound mutants), immunofluorescence, confocal imaging of hair cell bundle orientation in utricle and cochlea |
Journal of cell science |
High |
41208475
|
| 2025 |
STK32A (stk32a) mutant zebrafish display increased sleep and impaired sleep homeostasis. In zebrafish, stk32a acts downstream of neurotensin signaling and the serotonergic raphe to promote wakefulness. Pth4 neuron-induced sleep is suppressed in stk32a mutants, possibly through stk32a-expressing neurons in the prethalamus that express parathyroid hormone receptors, placing stk32a in a hypothalamic-brainstem sleep circuit. |
Zebrafish genetic screen (stk32a loss-of-function mutants), optogenetic stimulation of Pth4 neurons, genetic epistasis with noradrenergic LC and serotonergic raphe neuron ablation, sleep/wake behavioral quantification |
Current biology : CB |
Medium |
41406966
|
| 2025 |
stk32a mutation in zebrafish and mice causes increased sleep and impaired sleep homeostasis. stk32a acts downstream of neurotensin signaling and the serotonergic raphe. stk32a mutation reduces phosphorylation of neurofilament proteins in neurons that regulate motor activity and in lateral line hair cells that detect environmental stimuli; ablation of these stk32a-expressing cells phenocopies the sleep phenotype. Neurotensin signaling inhibits specific sensory and motor populations and blocks stimulus-evoked responses of neurons relaying hair cell sensory information, establishing stk32a as a conserved sleep regulator linking neuropeptidergic/neuromodulatory systems to homeostatic sleep drive through suppression of sensory and motor systems. |
Forward genetic screen in zebrafish informed by human GWAS; stk32a mutant behavioral analysis in zebrafish and mice; cell-type-specific ablation; phosphoproteomics (neurofilament phosphorylation); calcium imaging of sensory neuron responses; genetic epistasis with neurotensin and serotonergic raphe pathways |
bioRxivpreprint |
Medium |
bio_10.1101_2025.09.09.675098
|